已收盘 04-02 16:00:00 美东时间
-1.350
-3.25%
今日重点评级关注:瑞穗:维持RELMADA THERAPEUTICS"跑赢大市"评级,目标价从10美元升至19美元;奥本海默:维持Pelthos Therapeutics"跑赢大市"评级,目标价从60美元升至62美元
03-23 13:53
Stifel analyst Jonathan Siegmann maintains TAT Technologies (NASDAQ:TATT) with a Buy and raises the price target from $47 to $60.
03-20 23:56
CHARLOTTE, N.C., March 18, 2026 /PRNewswire/ -- TAT Technologies Ltd. (NASDAQ: TATT) (TASE: TAT Tech), a leading supplier of products and services for the commercial and military aviation in...
03-19 04:52
TAT Techs (NASDAQ:TATT) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.39 by 6.49 percent. This is a 20 percent increase over earnings of $0.30 per share from the same
03-19 04:27
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
TAT Technologies Ltd. (NASDAQ:TATT) (TASE: TAT Tech), a leading supplier of products and services for the commercial and military aviation industries and the ground defense industries, today announced that it has signed
03-12 05:18
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Benchmark analyst Ben Klieve maintains TAT Technologies (NASDAQ:TATT) with a Buy and raises the price target from $53 to $58.
02-04 22:29
今日重点评级关注:Ascendiant Capital:维持Maison Solutions"买入"评级,目标价从4.25美元升至4.5美元;HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从39美元升至50美元
2025-12-31 10:25